Physician

John Gillespie Stoner, D.O.

According to 2025 Medicare claims, John Stoner, D.O. (NPI: 1225289408) practices dermatology in the York-Hanover, PA market, with the plurality of this provider's patient population coming from York, PA. This provider's primary affiliated billing organization is DERMATOLOGY ASSOCIATES OF YORK INC (NPI: 1245204023; TIN: 232143100) and primary practice location at 17402-4643.

Stoner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,810 traditional Medicare patients, billed 7,888 HCPCS/CPT codes, and received $353,948 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,516 prescription claims across 652 beneficiaries totaling $965,765 in drug costs, led by Tremfya (Guselkumab). Open Payments data shows 21 records totaling $426. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $74,192 to $965,765. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$205K$410K2015 Medicare payment: $344,649 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $366,721 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $370,734 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $389,536 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $409,562 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $347,354 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $399,954 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $370,638 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $383,018 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $353,948 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,6928,037$344,649
20161,8149,239$366,721
20171,7989,305$370,734
20181,7978,999$389,536
20191,9688,831$409,562
20201,7587,514$347,354
20211,9458,444$399,954
20221,8658,102$370,638
20231,8808,291$383,018
20241,8107,888$353,948

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$483K$966K2015 Drug cost: $74,192 (USD; Tot_Drug_Cst)2016 Drug cost: $127,557 (USD; Tot_Drug_Cst)2017 Drug cost: $156,175 (USD; Tot_Drug_Cst)2018 Drug cost: $185,493 (USD; Tot_Drug_Cst)2019 Drug cost: $234,433 (USD; Tot_Drug_Cst)2020 Drug cost: $161,957 (USD; Tot_Drug_Cst)2021 Drug cost: $280,359 (USD; Tot_Drug_Cst)2022 Drug cost: $268,641 (USD; Tot_Drug_Cst)2023 Drug cost: $330,711 (USD; Tot_Drug_Cst)2024 Drug cost: $965,765 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015455928$74,192
20164991,141$127,557
2017437934$156,175
20184781,078$185,493
20194841,059$234,433
20205041,078$161,957
20215911,232$280,359
20225481,213$268,641
20235641,199$330,711
20246521,516$965,765

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more184201$89
17110Destruction of skin growth, 1-14 growths262302$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3661,659$60
17000Destruction of precancer skin growth, 1 growth755907$38
17003Destruction of precancer skin growth, 2-14 growths5502,997$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TremfyaGuselkumab221,176$303,972
Taltz AutoinjectorIxekizumab19588$142,887
OtezlaApremilast15630$111,758
Cosentyx Sensoready (2 Pens)Secukinumab13364$91,002
Clobetasol PropionateClobetasol Propionate1504,218$6,194

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$426ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Gillespie Stoner, D.O.?

Tedicare shows public-source Medicare data for John Gillespie Stoner, D.O. (NPI 1225289408), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Gillespie Stoner, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Gillespie Stoner, D.O.?

John Gillespie Stoner, D.O. is linked to DERMATOLOGY ASSOCIATES OF YORK INC (billing NPI 1245204023) in the available physician profile data.

Does John Gillespie Stoner, D.O. have Open Payments data?

John Gillespie Stoner, D.O. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.